Schizophrenia
RecruitingA study to evaluate the efficacy and safety of trospium chloride and xanomeline tartrate for the treatment of schizophrenia in adolescents aged 13 to 17 years
A study to evaluate the efficacy and safety of trospium chloride and xanomeline tartrate for the treatment of schizophrenia in adolescents aged 13 to 17 years
- Disease:Schizophrenia
- Substances:Trospium ChlorideXanomeline Tartrate
Romania- Participants:0–17 years
- Substances:Trospium Chloride
- Sponsor:Bristol-Myers Squibb Services Unlimited Company














